CTNNB1 and cancer: Increasing studies indicate that somatic mutations within the exon 3 of CTNNB1 usually stabilize β-catenin protein and activate Wnt signaling pathway in cancers [8, 10, 11], but the biological function of this novel CTNNB1 mutations in ACP remains unknown.